Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Biohit unveils interim financial report

Biohit unveils interim financial report

6th November 2009

Biohit has made its interim financial report available for the first nine months of 2009.

During this period, the firm’s net sales were 25.1 million euros (22.4 million British pounds), a drop from the 25.5 million euros reported for the corresponding period of 2008.

Operating profit amounted to 0.3 million euros, as compared to one million euros during the same period last year.

During the third quarter Biohit’s net sales decreased by seven per cent on the previous quarter, reaching 8.1 million euros, something it attributes to weaker demand for pipettes and seasonal variations.

However, this loss was offset by the growth of pipette tips sales, as well as its maintenance business and diagnostic test kits.

Biohit develops, manufacturers and markets diagnostic test systems for use in research, the healthcare industry and laboratories.

Its operations stretch worldwide, with bases in countries such as the UK, France, Germany, Finland and the US.

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.